Zobrazeno 1 - 4
of 4
pro vyhledávání: '"James Dongjoo Ham"'
Autor:
Yunpeng Liu-Lupo, James Dongjoo Ham, Swarna K. A. Jeewajee, Lan Nguyen, Toni Delorey, Azucena Ramos, David M. Weinstock, Aviv Regev, Michael T. Hemann
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Whole chromosome losses resulting in near-haploid karyotypes are found in a rare subgroup of treatment-refractory acute lymphoblastic leukemia. To systematically dissect the unique physiology and uncover susceptibilities that can be exploite
Externí odkaz:
https://doaj.org/article/acda13bfd53946019651b06a170fb474
Publikováno v:
EBioMedicine, Vol 59, Iss , Pp 102975- (2020)
Natural Killer (NK) cells and CD8+ cytotoxic T cells are two types of immune cells that can kill target cells through similar cytotoxic mechanisms. With the remarkable success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells for treating
Externí odkaz:
https://doaj.org/article/796f4e5b8731453eb7aed26455cab1a8
Autor:
Han Dong, James Dongjoo Ham, Guangan Hu, Guozhu Xie, Juliana Vergara, Yong Liang, Alaa Ali, Mubin Tarannum, Hannah Donner, Joanna Baginska, Yasmin Abdulhamid, Khanhlinh Dinh, Robert J. Soiffer, Jerome Ritz, Laurie H. Glimcher, Jianzhu Chen, Rizwan Romee
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Acute myeloid leukemia (AML) remains a therapeutic challenge, and a paucity of tumor-specific targets has significantly hampered the development of effective immune-based therapies. Recent paradigm-changing studies have shown that natural killer (NK)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4748a3d1f85933804560adb74c41bae
https://doi.org/10.1073/pnas.2122379119
https://doi.org/10.1073/pnas.2122379119
Publikováno v:
EBioMedicine, Vol 59, Iss, Pp 102975-(2020)
EBioMedicine
Elsevier
EBioMedicine
Elsevier
© 2020 The Author(s) Natural Killer (NK) cells and CD8+ cytotoxic T cells are two types of immune cells that can kill target cells through similar cytotoxic mechanisms. With the remarkable success of chimeric antigen receptor (CAR)-engineered T (CAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::849da866226738d910b3a40ed87727a6
http://www.sciencedirect.com/science/article/pii/S2352396420303510
http://www.sciencedirect.com/science/article/pii/S2352396420303510